Homburger and Davis Polk & Wardwell advised ADC Therapeutics on the deal. DC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced that it...
You must be a Standard 1 Year member to access this content.
Homburger advised CDR-Life in the transaction. CDR-Life Inc, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, announced the closing...
You must be a Standard 1 Year member to access this content.
Clifford Chance and Niederer Kraft Frey advised Partners Group on the deal. Lenz & Staehelin advised Climeworks. Homburger advised M&G . Partners Group invested in Climeworks,...
You must be a Standard 1 Year member to access this content.
Homburger advised Sunrise UPC on the transaction. Pestalozzi advised CH Media. Sunrise UPC and CH Media have announced a long-term strategic partnership to drive the expansion...
You must be a Standard 1 Year member to access this content.
Homburger AG, Bär & Karrer, Simpson Thacher & Bartlett LLP, and Allens acted as joint legal advisors to CSL. PJT Partners, BofA Securities and Goldman Sachs...
You must be a Standard 1 Year member to access this content.
Homburger advised Bergé Auto on the transaction, Binder Groesswang advised German Nissan Center Europe while Cerha Hempel advised Astara. Bergé Auto announced that it has reached...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised Stellantis on the deal, while Homburger advised Bergé Auto. Stellantis has agreed to sell FCA Switzerland SA to Bergé Auto with Bergé Auto taking...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised BNP Paribas and Deutsche Bank on the deal. Lenz & Staehelin acted as legal advisor to the Roche family pool. Bär & Karrer...
You must be a Standard 1 Year member to access this content.
Homburger advised HV Capital on the deal. Wenger Vieli advised Archlet. Archlet AG, a spin-off of ETH Zurich that develops and markets data-driven sourcing software, announced...
You must be a Standard 1 Year member to access this content.
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of...
You must be a Standard 1 Year member to access this content.
Homburger advised ADC Therapeutics SA on the agreement. ADC Therapeutics SA (NYSE: ADCT), a Swiss-based commercial-stage oncology-focused biotechnology company, announced that it had entered into a...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...
You must be a Standard 1 Year member to access this content.
